Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease

Schrag M, Crofton A, Zabel M, Jiffry A, Kirsch D, Dickson A, Mao XW, Vinters HV, Domaille DW, Chang CJ, Kirsch W.

J Alzheimers Dis. 2011;24(1):137-49. doi: 10.3233/JAD-2010-101503.

Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies

Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti R.

J Alzheimers Dis. 2011;24(1):175-85. doi: 10.3233/JAD-2010-101473.

Metabolome in progression to Alzheimer's disease

Orešič M, Hyötyläinen T, Herukka SK, Sysi-Aho M, Mattila I, Seppänan-Laakso T, Julkunen V, Gopalacharyulu PV, Hallikainen M, Koikkalainen J, Kivipelto M, Helisalmi S, Lötjönen J, Soininen H.

Transl Psychiatry. 2011 Dec 13;1(12):e57. doi: 10.1038/tp.2011.55.

Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability

Pennisi G, Ferri R, Lanza G, Cantone M, Pennisi M, Puglisi V, Malaguarnera G, Bella R.

J Neural Transm (Vienna). 2011 Apr;118(4):587-98. doi: 10.1007/s00702-010-0554-9. Epub 2011 Jan 5.

New lessons from the Alzheimer's Disease Neuroimaging Initiative

Salloway S.

Arch Neurol. 2011 Jan;68(1):19-21. doi: 10.1001/archneurol.2010.344.

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease

Roe CM, Fagan AM, Williams MM, Ghoshal N, Aeschleman M, Grant EA, Marcus DS, Mintun MA, Holtzman DM, Morris JC.

Neurology. 2011 Feb 8;76(6):501-10. doi: 10.1212/WNL.0b013e31820af900. Epub 2011 Jan 12.

Tapping into the biology of Alzheimer disease

Knopman DS.

Neurology. 2011 Feb 8;76(6):496-7. doi: 10.1212/WNL.0b013e31820af995. Epub 2011 Jan 12.

Overview and recent advances in neuropathology. Part 2: Neurodegeneration

Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, McLean C.

Pathology. 2011 Feb;43(2):93-102. doi: 10.1097/PAT.0b013e3283426eee.

Mapping out biomarkers for Alzheimer disease

Breteler MM.

JAMA. 2011 Jan 19;305(3):304-5. doi: 10.1001/jama.2010.2017.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1

Mayeux R, Reitz C, Brickman AM, Haan MN, Manly JJ, Glymour MM, Weiss CC, Yaffe K, Middleton L, Hendrie HC, Warren LH, Hayden KM, Welsh-Bohmer KA, Breitner JC, Morris JC.

Alzheimers Dement. 2011 Jan;7(1):15-34. doi: 10.1016/j.jalz.2010.11.005.

An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease

Mizukami K, Ishikawa M, Akatsu H, Abrahamson EE, Ikonomovic MD, Asada T.

Neuropathology. 2011 Oct;31(5):503-9. doi: 10.1111/j.1440-1789.2010.01193.x. Epub 2011 Jan 27.

Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease

Rahmadi A, Steiner N, Münch G.

Clin Chem Lab Med. 2011 Mar;49(3):385-91. doi: 10.1515/CCLM.2011.079. Epub 2011 Jan 31.

Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study

Acosta-Baena N, Sepulveda-Falla D, Lopera-Gómez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, Saldarriaga A, Lopera F.

Lancet Neurol. 2011 Mar;10(3):213-20. doi: 10.1016/S1474-4422(10)70323-9. Epub 2011 Feb 4.

Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease

Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Björkhem I, Cedazo-Mínguez A.

J Alzheimers Dis. 2011;24(4):669-79. doi: 10.3233/JAD-2011-101512.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias